As an open access journal, Journal of the Korean Neurological Association (JKNA) will follow the Principles of Transparency and Best Practice in Scholarly Publishing (https://doaj.org/bestpractice) developed by Committee on Publication Ethics (COPE), the Directory of Open Access Journals (DOAJ), the Open Access Scholarly Publishers Association (OASPA), and the World Association of Medical Editor (WAME).

Table of Contents

• 1. Website
• 2. Name of Journal
• 3. Peer Review Process
• 4. Ownership and Management
• 5. Governing Body
• 6. Editorial Team and Contact Information
• 7. Copyright and Licensing
• 8. Author Fees
• 9. Process for Identification of and Dealing with Allegations of Research Misconduct
• 10. Research & Publication Ethics
• 11. Publishing Schedule
• 12. Access
• 13. Archiving
• 14. Revenue Sources
• 15. Advertising
• 16. Direct Marketing

1. Website

The URL of official journal web site is https://jkna.org.

The JKNA team endeavors to make a good website. JKNA website demonstrates that care has been taken to ensure high ethical and professional standards. It does not contain any misleading information, including any attempt to mimic another journal/publisher’s site.

2. Name of Journal

The official journal title is Journal of the Korean Neurological Association (herein “JKNA”), the abbreviation of ISO is J Korean Neurol Assoc. Prior to launching JKNA thorough checks are made to ensure no journal of a similar name already exists.

3. Peer Review Process

Type of peer review: Double-blind review

Method of peer review
The JKNA has on online submission and peer review system at http://submit.jkna.org/.

JKNA reviews all manuscripts received. A manuscript is first reviewed for its format and adherence to the aims and scope of the journal. If the manuscript does not fit the aims and scope of the Journal or does not adhere to the Instructions for authors, it may be returned to the author immediately after receipt and without a review. Before reviewing, all submitted manuscripts are inspected by Similarity Check powered by iThenticate (https://www.crossref.org/services/similarity-check/), a plagiarism-screening tool.

JKNA uses double-blind review, which means that both the reviewer and author identities are concealed from the reviewers, and vice versa, throughout the review process. To facilitate this, authors need to ensure that their manuscripts are prepared in a way that does not give away their identity. If one or more of edtors are involved as authors, the editor(s) should not be involved in the peer reviewer selection, evaluation, or decision process. Submitted manuscripts will be reviewed by 2 or more experts in the corresponding field. The editor selects peer referees by recommendation of the Editorial Board members or from the specialist database owned by the Editorial Board. The Editorial Board may request authors to revise the manuscripts according to the reviewer’s opinion. After revising the manuscript, the author should upload the revised files with a reply to each item of the reviewer’s opinion. Additions and amendments to the revised manuscript should be highlighted in red. The author’s revisions should be completed within 60 days after the request. If it is not received by the due date, the Editorial Board will not consider it for publication. To extend the revision period to more than 60 days, the author should negotiate with the Editorial Board. The manuscript review process should be finished the second review. If the reviewers wish further review, the Editorial Board may consider it. The Editorial Board will make a final decision on the approval for publication of the submitted manuscripts and can request any further corrections, revisions, and deletions of the article text if necessary. Statistical editing is also performed if the data need professional statistical review by a statistician. The review and publication processes that are not described in the Instructions for Authors will be incorporated into the Editorial Policy Statements approved by the Council of Science Editor Board of Directors, available at: www.councilscienceeditors.org/. The peer review process takes usually four to 8 weeks after the manuscript submission.

4. Ownership and Management

1) This journal is owned by the publisher, the Korean Neurological Association.

2) Management team of a journal (https://jkna.org/about/editorial.php)

• Journal Manager
   Jong Seok Bae, Hallym University, Seoul, Korea

• Managers of the Review Process
   Jee-Eun Kim, Ewha Womans Univeristy, Seoul, Korea
   Yerim Kim, Hallym University, Seoul, Korea

• Ethics Editor
   Taekjoong Kim, Inje University, Busan, Korea

• Statistics Editor
   Hyunjin Son, Dong-A University, Busan, Korea

• English Editor
   P.J. Kolston, PhD, English Science Editing, New Zealand

• Manuscript Editor
   Miseon Lim, JIN PUBLISHING & COMMUNICATION

• Website and JATS XML Producer
   Min Young Choi, M2PI, Korea

5/6. Governing Body / Editorial Team and Contact Information

The governing body is the journal's editorial board. The full names and affiliations of the journal’s editor and members of journal management team are displayed on the About (Editorial board & Journal management team) tab of journal homepage, and the contact information for the Editor and editorial office is on the About (Contact us) tab.

7. Copyright and Licensing

Copyright policy: Copyrights of all published materials are owned by the Korean Neurological Association. On behalf of co-author(s), corresponding author must complete and submit the journal's copyright transfer agreement, which includes a section on the disclosure of potential conflicts of interest based on the recommendations of the International Committee of Medical Journal Editor, "Uniform Requirements for Manuscripts Submitted to Biomedical Journals" (http://www.icmje.org/recommendations/). A copy of the form (https://jkna.org/authors/copyright_transfer_agreement.php) is made available to the submitting author within the submission process.

Licensing information: JKNA is an open-access journal distributed under the terms of the Creative Commons Attribution Non-commercial license, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited for non-commercial purpose (http://creativecommons.org/licenses/by-nc/4.0/).

Open access policy: Accepted peer-reviewed articles are freely available on the journal website for any user, worldwide, immediately upon publication without additional charge. To use the tables or figures of JKNA in other periodicals, books or media for scholarly, educational purposes, the process of permission request to the publisher of JKNA is not necessary. This is in accordance with the Budapest Open Access Initiative definition of open access. It also follows the open access policy of PubMed Central at United States National Library of Medicine (http://www.ncbi.nlm.nih.gov/pmc/). All the content of the journal is available immediately upon publication without embargo period.

8. Author Fees

There are no author submission fees or other publication-related charges. All cost for the publication process is supported by the Publisher. Journal of the Korean Neurological Association is a so-called platinum open access journal which does not charge author fees.

9. Process for Identification of and Dealing with Allegations of Research Misconduct

The editorial board of JKNA have carefully examined all submitted manuscripts whether these are abided by the ethical guidelines of the ICMJE and COPE. The published articles have involved the statements of conflict of interest, institutional review board, informed consent, and human/animal rights.

When the Journal faces suspected cases of research and publication misconduct such as a redundant (duplicate) publication, plagiarism, fabricated data, changes in authorship, undisclosed conflicts of interest, an ethical problem discovered with the submitted manuscript, a reviewer who has appropriated an author’s idea or data, complaints against editor, and other issues, the resolving process will follow the flowchart provided by the COPE (http://publicationethics.org/resources/flowcharts). The editorial board of JKNA will discuss the suspected cases and reach a decision. JKNA will not hesitate to publish errata, corrigenda, clarifications, retractions, and apologies when needed.

10. Publication Ethics

JKNA follows the Guideline on Good Publication of COPE (https://publicationethics.org), Recommendations of International Committee of Medical Journal Editor (http://www.icmje.org/recommendations), and Good Publication Practice Guidelines for Medical Journals of Korean Association of Medical Journal Editor (http://kamje.or.kr).

Our publication ethics are displayed on the Editorial Policy (Publication ethics) tab of journal homepage.

11. Publishing Schedule

JKNA is published 4 times (February 28, May 31, August 31, and November 30) a year. The e-pub versions of all articles have been promptly seen after the acceptance in the journal homepage.

12. Access

JKNA is an open-access journal distributed under the terms of the Creative Commons Attribution Non-commercial license, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited for non-commercial purpose (http://creativecommons.org/licenses/by-nc/4.0/). A free full-text service both in the XML and PDF formats is available immediately upon publication without embargo period.

13. Archiving

Full text of JKNA has been archived in National Library of Korea (http://www.nl.go.kr) from the first volume, 1983. According to the deposit policy (self-archiving policy) of (http://www.sherpa.ac.uk), authors cannot archive pre-print (i.e., pre-refereeing), but they can archive post-print (i.e., final draft post-refereeing). Authors can archive publisher’s version/PDF. JKNA provides the electronic backup and preservation of access to the journal content in the event the journal is no longer published by archiving in National Library of Korea.

14. Revenues sources

Revenue sources of journal are from the support of publisher (Korean Neurological Association), author fees, and advertising rates.

15. Advertising

Eligibility of the Advertised Products or Services
All products or services should be safe and reliable, and not cause any harm to the health and welfare of humans. Advertisements may promote information and technologies relevant for authors, editor, reviewers, and readers. Pharmaceutical products may also be considered.

Advertising is separate from content. Advertisers and sponsors have no advance knowledge of our editorial contents, nor do the editor have advance knowledge of advertisers. Content is never altered, added, or deleted to accommodate advertising. Advertisers and sponsors have no input regarding any of our editorial decisions or advertising policies.

We reserves the right to decline or cancel any advertisement at any time.

Advertisements for pharmaceutical products must conform to all regulations and policies of the Ministry of Food and Drug Safety, Republic of Korea in every respect.

Orders
Any individuals or organizations who are interested in advertising their products or services in the print copies of the journal or on its website are encouraged to contact the editorial office. The acceptance of advertisement will be discussed by the editorial board and will be ultimately approved by the publisher.

Advertisement Fee
For one print copy issue, the advertisement price for one whole page is USD 2,000. For banner advertisements on the website, the price is negotiable according to the duration of its exposure on the journal homepage. The price is usually greater than that for print copies.

Disclaimer
Liability: Neither the publisher nor the editor will be legally liable for advertisements presented in the journal. In addition, they cannot guarantee the accuracy, completeness, or usefulness of the information provided.

Endorsement: The publisher and the editor do not endorse any products or services that are advertised.

Disclaimer: Neither the publisher nor the authors will be legally liable for any of the content of advertisements, so readers must keep this in mind when reading or seeing advertisements.

16. Direct Marketing

Journal propagation has been done through the journal web site and distribution of an introduction pamphlet. Invitations to submit a manuscript are usually focused on the presenters at conferences, seminars, or workshops if the topic is related to the journal's aims and scope.